Con­sor­tium to au­to­mate cell ther­a­py man­u­fac­tur­ing wel­comes Ther­mo Fish­er and Charles Riv­er Labs

The world of cell ther­a­py man­u­fac­tur­ing is filled with un­cer­tain­ty and po­ten­tial road haz­ards. Mul­ti­ply Labs, a Cal­i­for­nia phar­ma man­u­fac­tur­er, is try­ing to cut back on those is­sues by en­abling the use of ro­bot­ics, and Thurs­day, the com­pa­ny an­nounced that it has two more heavy-hit­ters aboard.

Ther­mo Fish­er Sci­en­tif­ic and Charles Riv­er Lab­o­ra­to­ries are both join­ing the ro­bot­ic cell ther­a­py man­u­fac­tur­ing Con­sor­tium that Mul­ti­ply found­ed. The two are lead­ers in cell ther­a­py man­u­fac­tur­ing in their own right and will join a team round­ed out by UCSF and Cy­ti­va to de­vel­op a cGMP-com­pli­ant sys­tem that can make gene-mod­i­fied cell ther­a­pies at an in­di­vid­ual scale.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER